Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | AMGN | VRTX | ||
| Company | Bristol-Myers Squibb Company | Amgen Inc | Vertex Pharmaceutic | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 58.57 | 275.81 | 454.72 | ||
| High | 58.79 | 279.41 | 464.87 | ||
| Low | 57.59 | 273.86 | 450.00 | ||
| Last | 58.37 | 278.26 | 463.98 | ||
| Change | -0.32 | -0.06 | +7.01 | ||
| % Change | -0.55% | -0.02% | +1.53% | ||
| Volume | 9,533,695 | 4,174,100 | 1,220,600 | ||
| 20-Day Average Volume | 11,525,010 | 4,558,985 | 1,393,970 | ||
| Previous Close | 58.69 | 278.32 | 456.97 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 57.96 | 293.66 | 473.23 | ||
| 20-Day Raw Stochastic | 61.88% | 29.04% | 25.35% | ||
| 20-Day Relative Strength | 58.04% | 33.90% | 47.01% | ||
| Weighted Alpha | +24.81 | -4.57 | +23.17 | ||
| Today's Opinion | 100% Buy | 72% Sell | 8% Sell | ||
| Previous Opinion | 100% Buy | 72% Sell | 8% Sell | ||
| Last Month's Opinion | 88% Buy | 8% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.63% since 11/26/24 | -0.62% since 11/26/24 | -0.66% since 11/26/24 | ||
| Low | 57.59 on 12/04/24 | 273.86 on 12/04/24 | 450.00 on 12/04/24 | ||
| High | 60.09 on 12/03/24 | 283.64 on 11/29/24 | 470.93 on 11/29/24 | ||
| 1-Month | |||||
| %Chg | +5.27% since 11/04/24 | -12.20% since 11/04/24 | -1.87% since 11/04/24 | ||
| Low | 53.97 on 11/08/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | ||
| High | 61.08 on 11/11/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | ||
| 3-Month | |||||
| %Chg | +16.83% since 09/04/24 | -15.84% since 09/04/24 | -3.05% since 09/04/24 | ||
| Low | 47.55 on 09/09/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | ||
| High | 61.08 on 11/11/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | ||
| 6-Month | |||||
| %Chg | +39.81% since 06/04/24 | -9.47% since 06/04/24 | -2.31% since 06/04/24 | ||
| Low | 39.35 on 07/05/24 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | ||
| High | 61.08 on 11/11/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 119,033,712 | 149,606,192 | 117,683,024 | ||
| Shares Outstanding, K | 2,028,177 | 537,533 | 257,529 | ||
| Annual Sales | 45,006,000,000 | 28,190,000,000 | 9,869,200,000 | ||
| Annual Net Income | 8,025,000,000 | 6,717,000,000 | 3,619,600,000 | ||
| Last Quarter Sales | 11,892,000,000 | 8,503,000,000 | 2,771,900,000 | ||
| Last Quarter Net Income | 1,211,000,000 | 2,830,000,000 | 1,045,400,000 | ||
| 60-Month Beta | 0.45 | 0.55 | 0.36 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.80 on 10/31/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | ||
| Latest Earnings Date | 10/31/24 | 10/30/24 | 11/04/24 | ||
| Most Recent Dividend | 0.600 on 10/04/24 | 2.250 on 11/18/24 | N/A | ||
| Next Ex-Dividends Date | 10/04/24 | 11/18/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 51.23 | 14.47 | 0.00 | ||